Biological Dynamics will present a talk, "A Novel Technology to Isolate Nanoparticles and Macromolecules from Complex Biological Fluids", from 11:05 am to 11:25 am on Friday, November 10th at the AACC Emerging Clinical & Laboratory Diagnostics in Healthcare Ecosystem conference.
Biological Dynamics will attend the ASCO Annual Meeting June 2 – 6, 2017 in Chicago, IL. This meeting, which is attended by 30,000 oncology professionals from around the world, will provide education sessions presented by world-renowned leaders in the field of oncology. Sessions will focus on state-of-the-art treatment modalities, new therapies, and ongoing controversies.
Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.
